申请人:Cheon Hyae Gyeong
公开号:US20070185109A1
公开(公告)日:2007-08-09
The inventive indene derivatives of formula (I) are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs), causing no adverse side effects, and thus, they are useful for the treatment and prevention of disorders modulated by PPARs, i.e., metabolic syndromes such as diabetes, obesity, arteriosclerosis, hyperlipidemia, hyperinsulinism and hypertension, inflammatory diseases such as osteoporosis, liver cirrhosis and asthma, and cancer.
公式(I)的创新茚衍生物能够选择性地调节过氧化物酶体增殖物激活受体(PPARs)的活性,不会引起不良副作用,因此它们对于治疗和预防受PPARs调节的疾病非常有用,例如代谢综合症,如糖尿病,肥胖症,动脉硬化,高脂血症,高胰岛素血症和高血压,以及炎症性疾病,例如骨质疏松,肝硬化和哮喘,以及癌症。